Ampicillin – Uses, Mechanism and Side Effects

What is Ampicillin?

Ampicillin is a broad-spectrum antibiotic and a member of the aminopenicillin subclass of beta-lactam antibiotics. First developed in the 1960s, it remains one of the most widely used antibiotics globally. Ampicillin is effective against a broad range of gram-positive and gram-negative bacteria and is used both for the treatment and, in some cases, the prevention of bacterial infections.

Indications – When is Ampicillin Used?

Ampicillin is prescribed for a wide variety of bacterial infections, including:

• Respiratory tract infections such as bronchitis, pneumonia, and sinusitis
• Urinary tract infections such as cystitis and pyelonephritis (kidney infection)
• Gastrointestinal infections, including those caused by Salmonella or Shigella species
• Meningitis (inflammation of the membranes surrounding the brain), especially in newborns and young children
• Endocarditis (infection of the inner lining of the heart), often in combination with other antibiotics
• Skin and soft tissue infections
• Sepsis (bloodstream infection) caused by susceptible organisms

Mechanism of Action

Ampicillin exerts its antibacterial effect by inhibiting bacterial cell wall synthesis. It works by binding to penicillin-binding proteins (PBPs) — enzymes that are essential for building and maintaining the structural integrity of the bacterial cell wall. By blocking these proteins, ampicillin prevents the cross-linking of peptidoglycan, a key structural component of the cell wall. Without an intact cell wall, bacteria are unable to withstand internal osmotic pressure and ultimately die. This makes ampicillin a bactericidal agent, meaning it actively kills bacteria rather than simply inhibiting their growth.

Administration and Dosage

Ampicillin can be administered orally (as capsules or tablets), intravenously (directly into a vein), or intramuscularly (into a muscle). The appropriate dose depends on:

• The type and severity of the infection
• The age and body weight of the patient
• The patient's kidney function
• The causative organism and its susceptibility profile

Typical adult doses range from 250 mg to 3 g every 6 hours, depending on the clinical situation. Higher doses may be necessary for severe infections such as meningitis. Treatment duration is generally 5 to 14 days. Dosage should always be determined by a qualified healthcare provider.

Side Effects

Like all antibiotics, ampicillin can cause side effects. Common and clinically important side effects include:

• Skin rash: A maculopapular (measles-like), non-allergic rash is relatively common, particularly in patients who have infectious mononucleosis (glandular fever).
• Allergic reactions: These can range from mild skin reactions to the rare but life-threatening anaphylaxis. Patients with a known penicillin allergy should not take ampicillin.
• Gastrointestinal complaints: Nausea, vomiting, diarrhea, and abdominal discomfort may occur.
• Disruption of gut flora: Ampicillin can alter the natural balance of intestinal bacteria and, in rare cases, may trigger Clostridioides difficile-associated colitis.
• Superinfections: Due to its broad spectrum of activity, resistant organisms or fungi (e.g., Candida) may overgrow during treatment.

Resistance and Beta-Lactamases

A significant clinical challenge with ampicillin is growing bacterial resistance. Many bacteria produce enzymes called beta-lactamases that break down the beta-lactam ring of ampicillin, rendering it ineffective. To address this, ampicillin is frequently combined with a beta-lactamase inhibitor such as sulbactam. This combination (ampicillin-sulbactam) significantly broadens the spectrum of activity and overcomes many resistance mechanisms.

Contraindications

Ampicillin should not be used in patients with:

• A known hypersensitivity to penicillins or other beta-lactam antibiotics
• Concurrent infectious mononucleosis (glandular fever), as the risk of a severe skin rash is greatly increased
• Severe renal impairment (dose adjustment is required in moderate cases)

References

1. World Health Organization (WHO) – Model List of Essential Medicines, 23rd Edition (2023). Available at: https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2023.02
2. Brunton L.L. et al. – Goodman & Gilman's The Pharmacological Basis of Therapeutics. 14th Edition. McGraw-Hill Education, 2022.
3. Lode H. et al. – Aminopenicillins in clinical practice. Clinical Microbiology and Infection, 2007. DOI: 10.1111/j.1469-0691.2007.01671.x